Where Opportunity Is Found - Research & Analysis on Medicis Pharmaceutical Corp and Akorn, Inc.
* Reuters is not responsible for the content in this press release.
HONG KONG, Jun 13 (Marketwire) -- This morning, www.MarketFoundations.com announced new reports highlighting Medicis Pharmaceutical Corp (NYSE: MRX) and Akorn, Inc. (NASDAQ: AKRX). Free research downloads are available at www.MarketFoundations.com/index.php?coa=MRX&cob=AKRX. With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules. Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion. Market Foundations is releasing new coverage on Medicis Pharmaceutical Corp for its current position within the healthcare industry. Medicis Pharmaceutical Corporation (Medicis) together with its wholly owned subsidiaries is an independent specialty pharmaceutical company engaged in the development and marketing of products for the treatment of dermatological and aesthetic conditions in the United States and Canada. The full research report on Medicis Pharmaceutical Corp (NYSE: MRX) is available here: www.MarketFoundations.com/index.php?coa=MRX. Market Foundations has released research on Akorn, Inc. for its changing role within the healthcare industry. Akorn, Inc. manufactures and markets diagnostic and therapeutic ophthalmic pharmaceuticals, as well as hospital drugs and injectable pharmaceuticals. In addition, the Company has marketed and distributed vaccines purchased from outside sources. The Company operates in three segments: ophthalmic, hospital drugs & injectables, and contract services. The full research report on Akorn, Inc. (NASDAQ: AKRX) is available here: www.MarketFoundations.com/index.php?cob=AKRX. About Market Foundations By providing members with financial information services, we provide the foundation investors need to build investing intelligence. The difference between consistently making good investments or bad investments is nothing more than the right information at the right time. Contact: Gemma Cunningham Email: contact@MarketFoundations.com www.MarketFoundations.com Copyright 2012, Marketwire, All rights reserved. -0-